Board Meetings for APLLTD
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| APLLTD | Alembic Pharmaceuticals Limited | 08 May 2019 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters | |
| APLLTD | Alembic Pharmaceuticals Limited | 19 Mar 2019 | Other business matters | Inter-alia to consider and approve the issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 150 Crores on Private Placement Basis under Tranche III, Subject to bidding by the eligible investors on the Electronic Book Platform (EBP) provided by National Stock Exchanges of India Limited on March 18, 2019 and acceptance by the Company. | |
| APLLTD | Alembic Pharmaceuticals Limited | 22 Jan 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters | |
| APLLTD | Alembic Pharmaceuticals Limited | 14 Dec 2018 | Other business matters | Inter alia to consider and approve the issue and allotment of Unsecured Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 350 Crores on Private Placement Basis. | |
| APLLTD | Alembic Pharmaceuticals Limited | 06 Dec 2018 | Fund Raising | To consider Fund Raising | |
| APLLTD | Alembic Pharmaceuticals Limited | 22 Oct 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2018 and other business matters | |
| APLLTD | Alembic Pharmaceuticals Limited | 10 Sept 2018 | Fund Raising | To consider the proposal for issue of Non-Convertible Debentures on Private Placement Basis | |
| APLLTD | Alembic Pharmaceuticals Limited | 26 Jul 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters | |
| APLLTD | Alembic Pharmaceuticals Limited | 16 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| APLLTD | Alembic Pharmaceuticals Limited | 31 Jan 2018 | Results | Inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended on December 31, 2017. | |
| APLLTD | Alembic Pharmaceuticals Limited | 07 Nov 2017 | Results/Others | inter to consider and approve Unaudited Financial Results for the quarter and half year ended on September 30, 2017. | |
| APLLTD | Alembic Pharmaceuticals Limited | 20 Jul 2017 | Results | inter- alia to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30, 2017. | |
| APLLTD | Alembic Pharmaceuticals Limited | 03 May 2017 | Results/Dividend | inter alia, to transact the following business: 1. To consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2017. 2. To consider and recommend dividend on Equity Shares, if any, for the financial year ended March 31, 2017. | |
| APLLTD | Alembic Pharmaceuticals Limited | 25 Jan 2017 | Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months period ended on December 31, 2016. | |
| APLLTD | Alembic Pharmaceuticals Limited | 25 Oct 2016 | Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2016. |